Bupleurum chinense

Bupleurum chinense is a traditional Chinese medicinal herb whose primary bioactive compounds, saikosaponins (particularly saikosaponin-a and saikosaponin-d), drive its anti-inflammatory and hepatoprotective effects. These triterpenoid saponins modulate immune signaling by inhibiting complement cascade components and suppressing pro-inflammatory cytokine release.

Origin & History

Bupleurum chinense DC. is a perennial herbaceous plant in the Apiaceae family, native to East Asia including China, where its roots (Bupleuri Radix) are used medicinally. The roots are harvested, dried, and extracted using alcohol or water to yield liquid extracts, powders, or saponin-rich fractions.

Historical & Cultural Context

Bupleurum chinense roots have been used in Asian traditional medicine for centuries, particularly in Chinese medicine, to treat common cold, inflammatory disorders, hepatitis, cancer, and fever. The plant is officially recognized in Chinese, Japanese, Korean Pharmacopoeias and WHO monographs on medicinal plants.

Health Benefits

• Anti-inflammatory effects through inhibition of complement activation pathways (C1s, C3, C4) and cytokine modulation - based on in vitro studies only
• Hepatoprotective properties demonstrated by reduction of AST/ALT levels in animal models exposed to hepatotoxins - preliminary evidence only
• Antiviral activity against hepatitis B and other viruses shown in laboratory studies - no human clinical data available
• Immunomodulatory effects through prostaglandin synthesis modulation - based solely on preclinical research
• Potential gastroprotective effects from polysaccharide components - limited to animal studies

How It Works

Saikosaponin-a and saikosaponin-d inhibit the classical complement pathway by suppressing C1s activation and reducing C3 and C4 protein levels, thereby dampening downstream inflammatory cascades. These compounds also suppress NF-κB nuclear translocation, reducing transcription of TNF-α, IL-6, and IL-1β. Additionally, saikosaponins appear to modulate glucocorticoid receptor sensitivity, potentiating cortisol signaling and contributing to immunosuppressive effects.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for Bupleurum chinense were identified in the research dossier. All available evidence comes from in vitro and animal studies examining saikosaponin mixtures and extracts, with no PMIDs provided for any human studies.

Clinical Summary

Evidence for Bupleurum chinense is predominantly derived from in vitro cell studies and rodent models; robust human clinical trial data remain sparse. Animal studies using carbon tetrachloride-induced hepatotoxicity models have demonstrated statistically significant reductions in serum AST and ALT levels following saikosaponin administration, suggesting hepatoprotective potential. The European Medicines Agency (EMA) has evaluated Bupleurum root under its monograph framework, acknowledging traditional use for relief of fatigue and stress-related symptoms but noting insufficient clinical evidence to establish well-established medicinal use. No large-scale randomized controlled trials in humans have confirmed efficacy for any indication, meaning all purported benefits carry a preliminary or traditional-use evidence classification.

Nutritional Profile

Bupleurum chinense (Chinese thoroughwax root) is a medicinal herb rather than a food ingredient, so conventional macronutrient profiling is not its primary characterization. Dried root contains approximately 60-70% carbohydrates (predominantly polysaccharides including bupleuran 2IIb and 2IIc at roughly 3-8% of dry weight), 8-12% crude fiber, 5-8% protein (limited amino acid data available), and 2-5% lipids. Key bioactive compounds are the primary focus: Saikosaponins (triterpene glycosides) are the principal active constituents, present at 0.3-2.5% of dry root weight, with saikosaponin-a, saikosaponin-b2, saikosaponin-c, and saikosaponin-d as the dominant forms; saikosaponin-d is considered most pharmacologically potent. Polysaccharides (bupleurans) occur at 3-8% dry weight and are associated with immunomodulatory effects. Flavonoids including rutin, isorhamnetin, and narcissin are present at approximately 0.1-0.5% dry weight. Volatile oils constitute roughly 0.1-0.3%, containing compounds such as 2-methyl cyclopentanone and caprylic acid. Polyacetylenes (including bupleurumol) are present at trace levels (<0.1%). Phenylpropanoids including chlorogenic acid are detected at approximately 0.05-0.2%. Sterols (alpha-spinasterol, stigmasterol) occur at roughly 0.1-0.3% dry weight. Mineral content includes calcium (~800-1200 mg/100g dry), potassium (~1500-2000 mg/100g dry), iron (~15-25 mg/100g dry), and magnesium (~200-400 mg/100g dry), though bioavailability from dried root preparations is low due to matrix binding. Bioavailability of saikosaponins is significantly enhanced by hot water decoction (traditional preparation) compared to raw consumption; saikosaponins undergo hepatic hydrolysis to prosaikogenins, which are considered active metabolites. Standardized extracts are typically normalized to saikosaponin content (minimum 0.3% per pharmacopeial standards in some Asian regulatory frameworks). Note: This ingredient is used in gram-level therapeutic doses (3-9g dried root per day in traditional contexts), not as a conventional food source, so nutritional contribution to diet is negligible.

Preparation & Dosage

No clinically studied dosage ranges for human use are available. Preclinical studies used concentrations of 100 µg/ml for extracts or 1 mg/ear for saponins in animal models, but human dosing has not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, Schisandra chinensis, Turmeric, Astragalus, Licorice root

Safety & Interactions

Bupleurum chinense has been associated with hepatotoxicity in rare case reports, paradoxically contradicting its traditional hepatoprotective reputation, particularly when used in high doses or prolonged regimens. Common adverse effects include gastrointestinal upset, nausea, and increased bowel movements. It may potentiate immunosuppressive drugs and interfere with corticosteroid metabolism due to glucocorticoid receptor modulation, warranting caution in patients on prednisone or cyclosporine. Bupleurum is not recommended during pregnancy or breastfeeding due to insufficient safety data, and individuals with pre-existing liver disease should use it only under medical supervision.